Products

Product Description

Human recombinant monoclonal antibody raised against SARS-CoV-2 Beta Variant S.SARS-CoV-2,Coronavirus,COVID-19,COVID19,Wuhan virus,Wuhanvirus,Recombinant Antibody,Recombinant Antibodies,Recombinant Monoclonal Antibody,RecomAb,Recombinant Ab,Recombinant Monoclonal Antibodies,Recombinant Abs

Antibody Species

Human

Immunogen

Recombinant protein corresponding to SARS-CoV-2 Variant B.1.351 S.

Reactivity

SARS-CoV-2

Specificity

Reacts with RBD domain of spike protein of SARS-CoV-2, including South Africa variant (B.1.351) and UK variant (B.1.1.7).

Form

Liquid

Preparation Method

This antibody is a CHO expressed recombinant antibody. It has the characteristic human Fc domain.

Purification

Affinity chromatography

Isotype

Human IgG

Recommend Usage

ELISA
Neutralization Assay
The optimal working dilution should be determined by the end user.

Storage Buffer

In PBS (40% glycerol)

Storage Instruction

Store at 4°C is stable for 6 months from the date of shipment. For long term storage, store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Note

Result Data

Pseudoviral particle (PP) infection assay challenged by SARS-CoV-2 Variant B.1.351 S recombinant monoclonal antibody (Cat # RAB01067).

HEK293-ACE2 cells infected with SARS-CoV-2 pseudoviral particles under various amounts of SARS-CoV-2 Variant B.1.351 S recombinant monoclonal antibody (Cat # RAB01067), with IC50 of 42.8 ng/mL (SARS-CoV-2 Pseudoviral Particles, D614G) and 45 ng/mL (SARS-CoV-2 Pseudoviral Particles, South Africa Variant).